Semaglutide & Alzheimer’s: A New Hope in Neurodegenerative Research
Recent years have witnessed groundbreaking discoveries in the realm of pharmaceuticals, especially those involving metabolic and neurodegenerative conditions. One such development gaining attention is the potential link between semaglutide and Alzheimer’s disease. Originally developed to treat type 2 diabetes and later approved for obesity management, semaglutide — a GLP-1 receptor agonist — is now under … Read more